These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27331599)

  • 1. Comparative Cost Analysis of Surgical and PrePex Device Male Circumcision in Zimbabwe and Mozambique.
    Schutte C; Tshimanga M; Mugurungi O; Come I; Necochea E; Mahomed M; Xaba S; Bossemeyer D; Ferreira T; Macaringue L; Chatikobo P; Gundididza P; Hatzold K
    J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S96-S100. PubMed ID: 27331599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost analysis of integrating the PrePex medical device into a voluntary medical male circumcision program in Zimbabwe.
    Njeuhmeli E; Kripke K; Hatzold K; Reed J; Edgil D; Jaramillo J; Castor D; Forsythe S; Xaba S; Mugurungi O
    PLoS One; 2014; 9(5):e82533. PubMed ID: 24801515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating Opportunities for Achieving Cost Efficiencies Through the Introduction of PrePex Device Male Circumcision in Adult VMMC Programs in Zambia and Zimbabwe.
    Vandament L; Chintu N; Yano N; Mugurungi O; Tambatamba B; Ncube G; Xaba S; Mpasela F; Muguza E; Mangono T; Madidi N; Samona A; Tagar E; Hatzold K
    J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S90-5. PubMed ID: 27331598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the cost of adult voluntary medical male circumcision in a mixed (surgical and PrePex) site compared to a hypothetical PrePex-only site in South Africa.
    Kim HY; Lebina L; Milovanovic M; Taruberekera N; Dowdy DW; Martinson NA
    Glob Health Action; 2015; 8():29116. PubMed ID: 26679407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the Cost of Early Infant Male Circumcision in Zimbabwe: Results From a Randomized Noninferiority Trial of AccuCirc Device Versus Mogen Clamp.
    Mangenah C; Mavhu W; Hatzold K; Biddle AK; Madidi N; Ncube G; Mugurungi O; Ticklay I; Cowan FM; Thirumurthy H
    J Acquir Immune Defic Syndr; 2015 Aug; 69(5):560-6. PubMed ID: 26017658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Cost of Early Infant Male Circumcision by Nurse-Midwives and Doctors in Zimbabwe.
    Mangenah C; Mavhu W; Hatzold K; Biddle AK; Ncube G; Mugurungi O; Ticklay I; Cowan FM; Thirumurthy H
    Glob Health Sci Pract; 2016 Jul; 4 Suppl 1(Suppl 1):S68-75. PubMed ID: 27413085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phase II Randomized Controlled Trial Comparing Safety, Procedure Time, and Cost of the PrePex™ Device to Forceps Guided Surgical Circumcision in Zimbabwe.
    Tshimanga M; Mangwiro T; Mugurungi O; Xaba S; Murwira M; Kasprzyk D; Montaño DE; Nyamukapa D; Tambashe B; Chatikobo P; Gundidza P; Gwinji G
    PLoS One; 2016; 11(5):e0156220. PubMed ID: 27227679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse event profile of a mature voluntary medical male circumcision programme performing PrePex and surgical procedures in Zimbabwe.
    Bochner AF; Feldacker C; Makunike B; Holec M; Murenje V; Stepaniak A; Xaba S; Balachandra S; Tshimanga M; Chitimbire V; Barnhart S
    J Int AIDS Soc; 2017 Feb; 19(1):21394. PubMed ID: 28362066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of the PrePex Male Circumcision Device: Results From Pilot Implementation Studies in Mozambique, South Africa, and Zambia.
    Feldblum P; Martinson N; Bvulani B; Taruberekera N; Mahomed M; Chintu N; Milovanovic M; Hart C; Billy S; Necochea E; Samona A; Mhazo M; Bossemeyer D; Lai JJ; Lebinai L; Ashengo TA; Macaringue L; Veena V; Hatzold K
    J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S43-8. PubMed ID: 27331589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety Profile of PrePex Male Circumcision Device and Client Satisfaction With Adolescent Males Aged 13-17 Years in Zimbabwe.
    Tshimanga M; Hatzold K; Mugurungi O; Mangwiro T; Ncube G; Xaba S; Chatikobo P; Gundidza P; Samkange C; Dhlamini R; Murwira M; Gwinji G
    J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S36-42. PubMed ID: 27331588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systems-based assessment of the PrePex device adverse events active surveillance system in Zimbabwe.
    Adamson PC; Tafuma TA; Davis SM; Xaba S; Herman-Roloff A
    PLoS One; 2017; 12(12):e0190055. PubMed ID: 29272320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PrePex device is unlikely to achieve cost-savings compared to the forceps-guided method in male circumcision programs in sub-Saharan Africa.
    Obiero W; Young MR; Bailey RC
    PLoS One; 2013; 8(1):e53380. PubMed ID: 23349708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reach and cost-effectiveness of the PrePex device for safe male circumcision in Uganda.
    Duffy K; Galukande M; Wooding N; Dea M; Coutinho A
    PLoS One; 2013; 8(5):e63134. PubMed ID: 23717402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the PrePex device an alternative for surgical male circumcision in adolescents ages 13-17 years? Findings from routine service delivery during active surveillance in Zimbabwe.
    Mavhu W; Hatzold K; Madidi N; Maponga B; Dhlamini R; Munjoma M; Xaba S; Ncube G; Mugurungi O; Cowan FM
    PLoS One; 2019; 14(3):e0213399. PubMed ID: 30856228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voluntary medical male circumcision service delivery in South Africa: The economic costs and potential opportunity for private sector involvement.
    Tchuenche M; Njeuhmeli E; Schütte C; Ngubeni L; Choge I; Martin E; Loykissoonlal D; Kiggundu V; Yansaneh A; Forsythe S
    PLoS One; 2018; 13(12):e0208698. PubMed ID: 30557330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Acceptability of the PrePex Device When Used in Routine Male Circumcision Service Delivery During Active Surveillance in Zimbabwe.
    Mavhu W; Hatzold K; Ncube G; Xaba S; Madidi N; Keatinge J; Dhodho E; Samkange CA; Tshimanga M; Mangwiro T; Mugurungi O; Njeuhmeli E; Cowan FM
    J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S63-8. PubMed ID: 27331593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative efficiency of demand creation strategies to increase voluntary medical male circumcision uptake: a study conducted as part of a randomised controlled trial in Zimbabwe.
    Mangenah C; Mavhu W; Garcia DC; Gavi C; Mleya P; Chiwawa P; Chidawanyika S; Ncube G; Xaba S; Mugurungi O; Taruberekera N; Madidi N; Fielding KL; Johnson C; Hatzold K; Terris-Prestholt F; Cowan FM; Bautista-Arredondo S
    BMJ Glob Health; 2021 Jul; 6(Suppl 4):. PubMed ID: 34275870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost Analysis of Adult Male Circumcision with the PrePex Device versus Surgery in Rwanda.
    Mutabazi V; Bitega JP; Muyenzi Ngeruka L; Nyemazi JP; Dain M; Kaplan SA; Karema C; Binagwaho A
    Urol Nurs; 2014; 34(6):303-11. PubMed ID: 26298926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa.
    Njeuhmeli E; Forsythe S; Reed J; Opuni M; Bollinger L; Heard N; Castor D; Stover J; Farley T; Menon V; Hankins C
    PLoS Med; 2011 Nov; 8(11):e1001132. PubMed ID: 22140367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling Impact and Cost-Effectiveness of Increased Efforts to Attract Voluntary Medical Male Circumcision Clients Ages 20-29 in Zimbabwe.
    Kripke K; Hatzold K; Mugurungi O; Ncube G; Xaba S; Gold E; Ahanda KS; Kruse-Levy N; Njeuhmeli E
    PLoS One; 2016; 11(10):e0164144. PubMed ID: 27783637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.